• Shop
  • Shopping cart
  • Contact Waters
  •  United States
    • China / 简体中文
    • Japan / 日本語
    • India / English
    • United Kingdom / English
    • Germany / Deutsch
    • France / Français
    • South Korea / 한국어
    • Canada / Français
    • Canada / English
    • Taiwan / 繁體中文
    • Brazil / Português
    • Italy / Italiano
    • Spain / Español
    • More...

Application of a Mass Confirmation Workflow for Biotherapeutics Screening

Library Number:
APNT135075434
Part Number:
720007027EN
Author(s):
Henry Shion, Scott J. Berger, Ying Qing Yu
Source:
Waters
Content Type:
Application Notes
Content Subtype:
Application Notes
Related Products:
ACQUITY UPLC and ACQUITY PREMIER Columns
 
Biopharmaceutical Analysis
 
ACQUITY UPLC I-Class PLUS System
 
UNIFI Scientific Information System
 
BioAccord LC-MS System for Biopharmaceuticals
 
waters_connect
 
BioResolve RP mAb Polyphenyl Consumables
Abstract / Summary

In the study, we report the development of a higher throughput intact mass confirmation workflow using the BioAccord LC-MS System operated under the control of waters_connect informatics. We have implemented a faster gradient LC-MS analysis in combination with an enhanced informatics capability for matching target mass of the proteins. In addition, a color-coded sample plate can be displayed to show the mass confirmation status of each sample using a simple custom calculation. The mass confirmation workflow was applied to reversed phase and native SEC LC-MS intact mass analysis, with a total LC runtime of 2.5 minutes for each analysis. This workflow should improve analytical efficiency of LC-MS intact mass analysis for the clone screening, process development, and other functions where sample throughput is a concern for biotherapeutics analysis.


Downloadable File(s)
Title Format File Size
Download PDF PDF 1124.85kB